These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 14730555)
1. Serum cystatin C assay for the detection of early renal impairment in diabetic patients. Xia LH; Bing XG; An XT J Clin Lab Anal; 2004; 18(1):31-5. PubMed ID: 14730555 [TBL] [Abstract][Full Text] [Related]
2. Beta2-microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy. Aksun SA; Ozmen D; Ozmen B; Parildar Z; Mutaf I; Turgan N; Habif S; Kumanlioğluc K; Bayindir O Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):195-200. PubMed ID: 15127324 [TBL] [Abstract][Full Text] [Related]
3. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes. Oddoze C; Morange S; Portugal H; Berland Y; Dussol B Am J Kidney Dis; 2001 Aug; 38(2):310-6. PubMed ID: 11479157 [TBL] [Abstract][Full Text] [Related]
4. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Mussap M; Dalla Vestra M; Fioretto P; Saller A; Varagnolo M; Nosadini R; Plebani M Kidney Int; 2002 Apr; 61(4):1453-61. PubMed ID: 11918752 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome. Demirtaş S; Bozbaş A; Akbay A; Yavuz Y; Karaca L Clin Chim Acta; 2001 Sep; 311(2):81-9. PubMed ID: 11566167 [TBL] [Abstract][Full Text] [Related]
6. Serum cystatin C as a marker of the renal function. Randers E; Kristensen JH; Erlandsen EJ; Danielsen H Scand J Clin Lab Invest; 1998 Nov; 58(7):585-92. PubMed ID: 9890342 [TBL] [Abstract][Full Text] [Related]
7. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy. Christensson AG; Grubb AO; Nilsson JA; Norrgren K; Sterner G; Sundkvist G J Intern Med; 2004 Dec; 256(6):510-8. PubMed ID: 15554952 [TBL] [Abstract][Full Text] [Related]
8. Interest of cystatin C in screening diabetic patients for early impairment of renal function. Perlemoine C; Beauvieux MC; Rigalleau V; Baillet L; Barthes N; Derache P; Gin H Metabolism; 2003 Oct; 52(10):1258-64. PubMed ID: 14564676 [TBL] [Abstract][Full Text] [Related]
9. Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old old. Van Den Noortgate NJ; Janssens WH; Delanghe JR; Afschrift MB; Lameire NH J Am Geriatr Soc; 2002 Jul; 50(7):1278-82. PubMed ID: 12133025 [TBL] [Abstract][Full Text] [Related]
10. Rapid and accurate assessment of glomerular filtration rate in patients with renal transplants using serum cystatin C. Risch L; Blumberg A; Huber A Nephrol Dial Transplant; 1999 Aug; 14(8):1991-6. PubMed ID: 10462282 [TBL] [Abstract][Full Text] [Related]
11. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Hoek FJ; Kemperman FA; Krediet RT Nephrol Dial Transplant; 2003 Oct; 18(10):2024-31. PubMed ID: 13679476 [TBL] [Abstract][Full Text] [Related]
12. Clinical value of serum cystatin C by ELISA for estimation of glomerular filtration rate. Xu X; Zou J; Ding X; Xin D; Ren Y J Clin Lab Anal; 2004; 18(2):61-4. PubMed ID: 15065209 [TBL] [Abstract][Full Text] [Related]
13. Use of serum cystatin C to detect early decline of glomerular filtration rate in type 2 diabetes. Yang YS; Peng CH; Lin CK; Wang CP; Huang CN Intern Med; 2007; 46(12):801-6. PubMed ID: 17575370 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of plasma cystatin C as a marker for glomerular filtration rate in patients with type 2 diabetes. Harmoinen AP; Kouri TT; Wirta OR; Lehtimäki TJ; Rantalaiho V; Turjanmaa VM; Pasternack AI Clin Nephrol; 1999 Dec; 52(6):363-70. PubMed ID: 10604644 [TBL] [Abstract][Full Text] [Related]
15. Serum cystatin C-based equation compared to serum creatinine-based equations for estimation of glomerular filtration rate in patients with chronic kidney disease. Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L Clin Nephrol; 2008 Jul; 70(1):10-7. PubMed ID: 18793543 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with type 2 diabetes mellitus. Mojiminiyi OA; Abdella N; George S Scand J Clin Lab Invest; 2000 Oct; 60(6):483-9. PubMed ID: 11129064 [TBL] [Abstract][Full Text] [Related]
17. Is serum cystatin C an accurate endogenous marker of glomerular filteration rate for detection of early renal impairment in patients with type 2 diabetes mellitus? El-Shafey EM; El-Nagar GF; Selim MF; El-Sorogy HA; Sabry AA Ren Fail; 2009; 31(5):355-9. PubMed ID: 19839834 [TBL] [Abstract][Full Text] [Related]
18. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. Perkins BA; Nelson RG; Ostrander BE; Blouch KL; Krolewski AS; Myers BD; Warram JH J Am Soc Nephrol; 2005 May; 16(5):1404-12. PubMed ID: 15788478 [TBL] [Abstract][Full Text] [Related]
19. Analysis of glomerular filtration rate, serum cystatin C levels, and renal resistive index values in cirrhosis patients. Ustundag Y; Samsar U; Acikgoz S; Cabuk M; Kiran S; Kulah E; Aydemir S Clin Chem Lab Med; 2007; 45(7):890-4. PubMed ID: 17617033 [TBL] [Abstract][Full Text] [Related]
20. Cystatin C: efficacy as screening test for reduced glomerular filtration rate. Herget-Rosenthal S; Trabold S; Pietruck F; Holtmann M; Philipp T; Kribben A Am J Nephrol; 2000; 20(2):97-102. PubMed ID: 10773608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]